Skip to content
Washington University School of Medicine in St. Louis

Hospital Medicine Virtual Journal Club

Menu
  • About
  • Archives
  • FAQs
  • How to Access Full-text Articles
  • How to Use
  • Privacy Policy and Terms of Use

Category: eur heart j acute cardiovasc care

Beta-blockers for post-acute coronary syndrome mid-range ejection fraction: a nationwide retrospective study.

eur heart j acute cardiovasc care • February 5, 2019

Hyponatremia at discharge is associated with adverse prognosis in acute heart failure syndromes with preserved ejection fraction: a report from the JASPER registry.

eur heart j acute cardiovasc care • January 23, 2019

Electrocardiography changes and their significance during treatment of patients with intermediate-high and high-risk pulmonary embolism.

eur heart j acute cardiovasc care • January 12, 2019

Atrial fibrillation detected initially during acute medical illness: A systematic review.

eur heart j acute cardiovasc care • November 8, 2018

Right bundle branch block in patients with suspected myocardial infarction.

eur heart j acute cardiovasc care • October 27, 2018

Outcomes of early and reversible renal impairment in patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention.

eur heart j acute cardiovasc care • October 18, 2018

Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.

eur heart j acute cardiovasc care • September 12, 2018

Assessment of early treatment response by rapid cardiothoracic ultrasound in acute heart failure: Cardiac filling pressures, pulmonary congestion and mortality.

eur heart j acute cardiovasc care • September 6, 2018

Clinical impact of mineralocorticoid receptor antagonists treatment after acute coronary syndrome in the real world: A propensity score matching analysis.

eur heart j acute cardiovasc care • August 18, 2018

Heart rate at admission is a predictor of in-hospital mortality in patients with acute coronary syndromes: Results from 58 European hospitals: The European Hospital Benchmarking by Outcomes in acute coronary syndrome Processes study.

eur heart j acute cardiovasc care • August 7, 2018

Follow Us!

Follow Us on FacebookFollow Us on TwitterFollow Us on Instagram

Journal Club via Email

The HMVJC Minute Podcast

Subscribe Now!
  • AnchorAnchor
  • Apple PodcastsApple Podcasts
  • BreakerBreaker
  • Google PodcastsGoogle Podcasts
  • iHeartRadioiHeartRadio
  • PocketCastsPocketCasts
  • PodbayPodbay
  • Radio PublicRadio Public
  • SpotifySpotify
  • TikTokTikTok
  • YouTubeYouTube

Recent Comments

  • Anonymous on Things We Do for No Reason™: Obtaining Urine Testing in Older Adults With Delirium Without Signs or Symptoms of Urinary Tract Infection
  • agario unblocked on Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
  • Ronald M. Chavin on What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak
  • An Examination of Ivermectin and Other Promising Medications in the Prevention and Treatment of COVID | Compounding Corner Pharmacy, Inc. on Montelukast in Hospitalized Patients Diagnosed with COVID-19
  • Nathan Martin on Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial

The HMVJC COVID Reading List

  • Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
  • Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
  • Elevated D-dimer and Adverse In-hospital Outcomes in COVID-19 Patients and Synergism with Hyperglycemia
  • Occurrence and outcomes of possible superadded infections in older adults with COVID-19-cohort study
  • Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: A randomized clinical trial
  • Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
  • Re-examining the widespread policy of stopping SGLT2 inhibitors during acute illness: A perspective based on the updated evidence
  • Tocilizumab Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study
  • Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized with COVID-19: A Blinded Randomized Placebo-Controlled Trial
  • Ivermectin for preventing and treating COVID-19

Links

  • WU School of Medicine
  • Dept. of Medicine
  • Division of Hospital Medicine
  • Becker Medical Library
  • Society of Hospital Medicine
  • Today's Hospitalist

Editor: Robert J. Mahoney, M.D., CCS-P, SFHM

Powered by
PubMed

©2022 Washington University in St. Louis